184 related articles for article (PubMed ID: 28699092)
1. Impact of venous invasion on the efficacy of adjuvant chemotherapy in elderly patients with stage III colorectal cancer.
Hoshino N; Kawada K; Hida K; Goto S; Uozumi R; Hasegawa S; Sugihara K; Sakai Y
Med Oncol; 2017 Aug; 34(8):138. PubMed ID: 28699092
[TBL] [Abstract][Full Text] [Related]
2. Low-dose capecitabine adjuvant chemotherapy in elderly stage II/III colorectal cancer patients (LC-ACEC): study protocol for a randomized controlled trial.
He Y; Liu P; Zhang Y; Deng X; Meng W; Wei M; Yang T; Wang Z; Qiu M
Trials; 2015 May; 16():238. PubMed ID: 26021722
[TBL] [Abstract][Full Text] [Related]
3. The expression of vascular endothelial growth factor determines the efficacy of post-operative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
Ogata Y; Matono K; Mizobe T; Ishibashi N; Mori S; Akagi Y; Ikeda S; Ozasa H; Murakami H; Shirouzu K
Oncol Rep; 2006 May; 15(5):1111-6. PubMed ID: 16596171
[TBL] [Abstract][Full Text] [Related]
4. Indication and efficacy of adjuvant chemotherapy with oral fluoropyrimidines for dukes' B colorectal cancer.
Yoshimatsu K; Umehara A; Ishibashi K; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Anticancer Res; 2006; 26(4B):3089-93. PubMed ID: 16886639
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy for the perineural invasion of colorectal cancer.
Suzuki T; Suwa K; Ogawa M; Eto K; Kawahara H; Fujita T; Ikegami M; Yanaga K
J Surg Res; 2015 Nov; 199(1):84-9. PubMed ID: 25935467
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III.
Yokota M; Kojima M; Nomura S; Nishizawa Y; Kobayashi A; Ito M; Ochiai A; Saito N
Dis Colon Rectum; 2014 Jul; 57(7):830-8. PubMed ID: 24901683
[TBL] [Abstract][Full Text] [Related]
7. Timing of adjuvant chemotherapy in colorectal cancer.
Dos Santos LV; Faria TM; Lima AB; Abdalla KC; de Moraes ED; Cruz MR; Lima JP
Colorectal Dis; 2016 Sep; 18(9):871-6. PubMed ID: 26900665
[TBL] [Abstract][Full Text] [Related]
8. Survival impact of surgical resection of primary tumor in patients with stage IV colorectal cancer: results from a large population-based cohort study.
Ahmed S; Leis A; Fields A; Chandra-Kanthan S; Haider K; Alvi R; Reeder B; Pahwa P
Cancer; 2014 Mar; 120(5):683-91. PubMed ID: 24222180
[TBL] [Abstract][Full Text] [Related]
9. Tumor Diameter is an Easy and Useful Predictor of Recurrence in Stage II Colorectal Cancer.
Maeda C; Hidaka E; Mori Y; Mukai S; Miyachi H; Sawada N; Ishida F; Kudo SE
Dig Surg; 2015; 32(5):338-43. PubMed ID: 26183549
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival benefits of adjuvant chemotherapy by decreasing incidence of tumor recurrence without delaying relapse in stage III colorectal cancer.
Tsai WS; Hsieh PS; Yeh CY; Chiang JM; Tang R; Chen JS; Changchien CR; Wang JY
Int J Colorectal Dis; 2011 Oct; 26(10):1329-38. PubMed ID: 21556841
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of perineural invasion in patients with stage II colorectal cancer.
Huh JW; Kim HR; Kim YJ
Ann Surg Oncol; 2010 Aug; 17(8):2066-72. PubMed ID: 20182809
[TBL] [Abstract][Full Text] [Related]
12. [Principles of oncologic drug therapy following surgery for bowel cancer].
Ristamäki R; Ålgars A
Duodecim; 2016; 132(12):1155-9. PubMed ID: 27483631
[TBL] [Abstract][Full Text] [Related]
13. Objective criteria for the grading of venous invasion in colorectal cancer.
Sato T; Ueno H; Mochizuki H; Shinto E; Hashiguchi Y; Kajiwara Y; Shimazaki H; Hase K
Am J Surg Pathol; 2010 Apr; 34(4):454-62. PubMed ID: 20216202
[TBL] [Abstract][Full Text] [Related]
14. The combined expression of Semaphorin4D and PlexinB1 predicts disease recurrence in colorectal cancer.
Ikeya T; Maeda K; Nagahara H; Shibutani M; Iseki Y; Hirakawa K
BMC Cancer; 2016 Jul; 16():525. PubMed ID: 27456345
[TBL] [Abstract][Full Text] [Related]
15. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
[TBL] [Abstract][Full Text] [Related]
16. Lymph Node Ratio as a Risk Factor for Recurrence After Adjuvant Chemotherapy in Stage III Colorectal Cancer.
Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Nishimura Y; Katoh H; Yamashita K; Watanabe M; Yamaguchi K
J Gastrointest Surg; 2017 May; 21(5):867-878. PubMed ID: 28251467
[TBL] [Abstract][Full Text] [Related]
17. Distinctive oncological features of stage IIIA colorectal cancer: Analysis of prognostic factors for selective adjuvant chemotherapy.
Park SY; Choi GS; Park JS; Kim HJ; Sakai Y; Hasegawa S; Watanabe T; Kim SH
J Surg Oncol; 2015 Jun; 111(7):882-90. PubMed ID: 25847023
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival.
Hotta T; Takifuji K; Arii K; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Oku Y; Yamaue H
Anticancer Res; 2006; 26(2B):1425-32. PubMed ID: 16619554
[TBL] [Abstract][Full Text] [Related]
19. The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
Ogata Y; Matono K; Sasatomi T; Ishibashi N; Ohkita A; Mizobe T; Ogo S; Ikeda S; Ozasa H; Shirouzu K
Cancer Chemother Pharmacol; 2006 May; 57(5):577-83. PubMed ID: 16133529
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
Yun HR; Kim HC; Yun SH; Lee WY
Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
